USD 2.68
(-7.59%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 3.82 Million USD | -92.63% |
2022 | 51.84 Million USD | 17182.0% |
2021 | 300 Thousand USD | 144.08% |
2020 | 122.91 Thousand USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 12.1 Million USD | 216.75% |
2024 Q2 | 24.33 Million USD | 101.07% |
2023 Q3 | -18.8 Million USD | -125.98% |
2023 FY | 3.82 Million USD | -92.63% |
2023 Q4 | 3.82 Million USD | 120.32% |
2023 Q2 | 72.38 Million USD | 13.02% |
2023 Q1 | 64.04 Million USD | 23.54% |
2022 Q1 | 1.07 Million USD | 94.01% |
2022 FY | 51.84 Million USD | 17182.0% |
2022 Q4 | 51.84 Million USD | 52009.85% |
2022 Q3 | -99.87 Thousand USD | -107.54% |
2022 Q2 | 1.32 Million USD | 22.77% |
2021 Q3 | 426.31 Thousand USD | -29.9% |
2021 Q2 | 608.13 Thousand USD | 990.61% |
2021 Q4 | 556.07 Thousand USD | 30.44% |
2021 FY | 300 Thousand USD | 144.08% |
2021 Q1 | -68.28 Thousand USD | 0.0% |
2020 FY | 122.91 Thousand USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Abbott Laboratories | 8.97 Billion USD | 99.957% |
Artivion, Inc. | 300.4 Million USD | 98.728% |
Avanos Medical, Inc. | 121.4 Million USD | 96.853% |
Butterfly Network, Inc. | -109.6 Million USD | 103.485% |
Butterfly Network, Inc. | -109.6 Million USD | 103.485% |
Bio-Rad Laboratories, Inc. | 1 Billion USD | 99.619% |
Boston Scientific Corporation | 8.62 Billion USD | 99.956% |
CONMED Corporation | 966.95 Million USD | 99.605% |
Edwards Lifesciences Corporation | -449.1 Million USD | 100.851% |
Paragon 28, Inc. | 36.39 Million USD | 89.503% |
Glaukos Corporation | 290.27 Million USD | 98.684% |
Globus Medical, Inc. | 53.11 Million USD | 92.808% |
Inspire Medical Systems, Inc. | -160.69 Million USD | 102.377% |
Integer Holdings Corporation | 1.01 Billion USD | 99.624% |
Medtronic plc | 24.76 Billion USD | 99.985% |
Myomo, Inc. | -6.27 Million USD | 160.925% |
Nevro Corp. | 117.61 Million USD | 96.752% |
Owlet, Inc. | -1.34 Million USD | 384.862% |
Penumbra, Inc. | 66.85 Million USD | 94.286% |
Vicarious Surgical Inc. | -37.99 Million USD | 110.055% |
Smith & Nephew plc | 2.78 Billion USD | 99.863% |
Sonendo, Inc. | 26.34 Million USD | 85.498% |
STERIS plc | 3.17 Billion USD | 99.88% |
Stryker Corporation | 10.02 Billion USD | 99.962% |
Vapotherm, Inc. | 102.66 Million USD | 96.279% |
Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | 99.932% |